Client is a biopharmaceutical company that develops medicines in areas of unmet need.
Intellectual property reform. 
S. 1137 - PATENT Act & HR 9 - Innovation Act Access and reimbursement for HCV products Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Funding for HCV and public health activities via appropriations. 

Pharmaceutical policy as it relates to payments under the 340B program.  

S.1287 - Viral Hepatitis Testing Act of 2015
CPT - Copyright/Patent/Trademark VET - Veterans MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS